Psyence Biomedical Ltd.
Price Action
Technical Summary
WEAKENINGPsyence Biomedical Ltd. is in a technical downtrend, trading below key resistance levels with a broken trend structure. Relative strength is leading (RS Rating: 84), indicating clear outperformance against the broad market. Earnings contraction of 28% provides fundamental context to the price action. However, price is extended 48% above the 50-day line, increasing the risk of a mean reversion.
Trend Template (Minervini)
Price vs Moving Averages
| Period | Value | Spread | Signal |
|---|---|---|---|
| 20 SMA | $6.22 | -4.65% | BELOW |
| 50 SMA | $3.99 | +48.48% | ABOVE |
| 100 SMA | $4.37 | +35.67% | ABOVE |
| 150 SMA | $8.37 | -29.15% | BELOW |
| 200 SMA | $12.53 | -52.68% | BELOW |
Price Performance
Technical Indicators
Risk Profile
Volume Analysis
Earnings Momentum
Growth Trends
Compounded Sales Growth
Compounded Profit Growth
Stock Price CAGR
Return on Equity
Key Metrics
Frequently Asked Questions
Is PBM in an uptrend right now?
PBM has a trend score of 1/4 based on Minervini's Stage Analysis. Currently showing broken structure - 1 of 4 trend criteria are met.
Is PBM overbought or oversold?
PBM's RSI (14) is 53. The stock is in neutral territory, neither overbought nor oversold.
Is PBM outperforming the market?
PBM has a Relative Strength (RS) Rating of 84 out of 99. Yes, PBM is a market leader, outperforming 84% of all stocks over the past 12 months.
Where is PBM in its 52-week range?
PBM is trading at $5.93, which is 8% of its 52-week high ($71.94) and 7% above its 52-week low ($0.69).
How volatile is PBM?
PBM has a Beta of 3.27 and 52-week volatility of 215%. It's more volatile than the S&P 500 - expect bigger swings.